神经母细胞瘤,版本2.2024,NCCN 瘤学临床实践指南
Rochelle Bagatell1, Julie R Park2, Sahaja Acharya3
11Abramson Cancer Center at the University of Pennsylvania | Children's Hospital of Philadelphia.
Journal of the National Comprehensive Cancer Network : JNCCN
|August 16, 2024
概括
本摘要介绍了第一个国家综合癌症网络 (NCCN) 神经母细胞瘤指南,为诊断和治疗这种常见的儿童癌症提供专家建议.
科学领域:
- 儿科瘤学 儿科瘤学
- 癌症治疗方法 癌症治疗方法
- 临床指南 临床指南
背景情况:
- 神经母细胞瘤是儿童最常见的额头外固体瘤.
- 有效的管理需要多学科的方法.
- 临床异质性需要量身定制的治疗策略.
研究的目的:
- 为介绍NCCN神经母细胞瘤指南的首次版本.
- 为神经母细胞瘤护理提供基于证据的建议.
- 引导临床医生进行诊断,风险分类和治疗选择.
主要方法:
- 由NCCN神经母细胞瘤小组开发,这是一个多学科专家小组.
- 包括儿科瘤学家,放射学家,病理学家,外科医生和辐射瘤学家.
- 基于共识的建议来自专家审查.
主要成果:
- 这些指南为神经母细胞瘤管理提供了全面的建议.
- 它们涵盖了诊断,风险分层和治疗选择.
- 这些建议是针对治疗儿科患者的临床医生.
结论:
- 关于神经母细胞瘤的NCCN指南为临床医生提供了至关重要的资源.
- 这些指导方针旨在标准化和优化对这种儿科恶性瘤的护理.
- 多学科的开发确保了对神经母细胞瘤治疗的整体方法.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...